How to Balance Hormones Before Pregnancy

Why Hormonal Balance Matters Before You Conceive

Conception and early embryo survival depend on a precisely timed hormonal cascade. Disruptions anywhere in that cascade, a TSH of 4.8 mIU/L, a fasting insulin of 22 µIU/mL, or a luteal-phase progesterone below 5 ng/mL, can prevent implantation or trigger early pregnancy loss before a woman even knows she is pregnant.

A 2019 analysis published in Fertility and Sterility found that subclinical hypothyroidism (TSH 2.5 to 10 mIU/L) was associated with a miscarriage rate roughly twice that of euthyroid controls [1]. These are not edge cases. Population surveys suggest that 5 to 10% of reproductive-age women have undiagnosed thyroid dysfunction [2].

The Six Hormone Axes Worth Addressing

Most clinicians organize preconception hormonal work around six axes:

1. Thyroid (TSH, free T4, TPO antibodies)
2. Insulin / glucose (fasting insulin, fasting glucose, HOMA-IR, HbA1c)
3. Progesterone (cycle day 21 serum level)
4. Estrogen (cycle day 3 estradiol, urine or serum estrogen metabolites)
5. Androgens (total testosterone, free testosterone, DHEA-S)
6. Prolactin (single fasting morning draw)

Addressing all six before conception gives a clinician a complete picture rather than a partial one. Missing one axis is common and often explains why a first round of interventions did not work.

When to Start

Three to six months before the target conception date is a practical minimum. Thyroid dose titration alone can take six to eight weeks to reflect in a new TSH. Correcting insulin resistance through diet, exercise, and inositol or metformin typically requires two to three menstrual cycles before ovulatory patterns normalize.

Thyroid Optimization: The Non-Negotiable First Step

The thyroid gland governs metabolic rate, ovarian function, and the uterine lining. The American Thyroid Association's 2017 guidelines state: "We recommend that TSH concentrations be maintained between the lower reference limit and 2.5 mIU/L in women who are planning a pregnancy and who require levothyroxine therapy" [3].

What TSH Range to Target Before Pregnancy

For women not yet on thyroid medication, a preconception TSH above 2.5 mIU/L warrants a conversation with a clinician, particularly if TPO antibodies are positive. Positive antibodies increase miscarriage risk even when TSH is within the standard laboratory range of 0.4 to 4.5 mIU/L [4].

Levothyroxine (brand names include Synthroid and Tirosint) remains the standard therapy. Dose is weight-based, typically 1.6 mcg/kg/day, but preconception and pregnancy requirements often exceed that starting point because placental hCG stimulates the thyroid from weeks 6 to 12.

TPO Antibodies and Pregnancy Loss

A 2010 RCT published in the Journal of Clinical Endocrinology and Metabolism (N=115) found that euthyroid women with positive TPO antibodies who received levothyroxine had a miscarriage rate of 3.5%, compared with 13.8% in untreated controls [4]. The absolute risk reduction is clinically meaningful. Any preconception thyroid panel should include TPO antibodies, not just TSH.

Adjusting Levothyroxine Once Pregnancy Is Confirmed

Once a home pregnancy test is positive, most guidelines recommend increasing the levothyroxine dose by approximately 25 to 30% immediately (the "two extra tablets per week" rule), then rechecking TSH at weeks 4 to 6 of gestation [3]. Waiting for the first obstetric appointment at week 8 to 10 may leave a fetal brain without adequate maternal thyroid hormone during the most sensitive window.

Insulin and Blood Sugar: The Fertility Signal Most Labs Miss

Fasting glucose alone does not diagnose insulin resistance. A woman can have a perfectly normal fasting glucose of 88 mg/dL alongside a fasting insulin of 25 µIU/mL, producing a HOMA-IR of 5.5, well above the cutoff of 2.0 that many reproductive endocrinologists use as their action threshold.

Calculating HOMA-IR

HOMA-IR = (fasting insulin in µIU/mL × fasting glucose in mg/dL) / 405.

A value above 2.0 to 2.5 suggests meaningful insulin resistance. A value above 3.5 is strongly associated with anovulation in PCOS populations [5].

PCOS and Insulin Resistance

PCOS affects 6 to 12% of reproductive-age women and is the most common cause of anovulatory infertility [6]. The 2018 international evidence-based PCOS guidelines (endorsed by the European Society of Human Reproduction and Embryology and the American Society for Reproductive Medicine) list lifestyle modification as first-line therapy, with metformin as an adjunct when lifestyle alone is insufficient [7].

Metformin 500 to 1,500 mg/day has been shown to restore ovulation in anovulatory PCOS and is generally continued through the first trimester under physician supervision. A Cochrane review (2012) found that metformin increased clinical pregnancy rates compared with placebo in women with PCOS (OR 1.93, 95% CI 1.42 to 2.64) [8].

Inositol as a First-Line Supplement

Myo-inositol 4 g/day is a well-studied, over-the-counter option with a favorable safety profile. A 2012 RCT (N=120) published in the European Review for Medical and Pharmacological Sciences found that myo-inositol 4 g plus folic acid 400 mcg daily restored spontaneous ovulation in 65% of anovulatory PCOS women over six months, compared with 50% on folic acid alone [9]. The combination of myo-inositol 2 g plus D-chiro-inositol 50 mg (a 40:1 ratio) may offer additional benefit for androgen reduction.

Dietary Patterns That Move HOMA-IR

A low-glycemic-index diet reducing refined carbohydrate intake by 30 to 50 g/day can lower fasting insulin by 15 to 20% over 12 weeks in insulin-resistant women, according to a 2013 trial published in Metabolism [10]. Resistance training three sessions per week adds an independent effect on glucose uptake that is roughly additive with dietary change.

Progesterone: The Hormone That Holds a Pregnancy

Progesterone is produced by the corpus luteum after ovulation and, after week 8 to 10 of gestation, by the placenta. Low luteal-phase progesterone is associated with recurrent implantation failure and early pregnancy loss.

How and When to Test Progesterone

Test progesterone on cycle day 21 in a 28-day cycle. More precisely, progesterone should be drawn seven days after ovulation, confirmed by basal body temperature charting or an LH surge test. A result above 10 ng/mL confirms ovulation occurred and that the corpus luteum is functioning adequately. Values of 5 to 10 ng/mL suggest luteal phase deficiency. Values below 5 ng/mL may indicate anovulation.

Progesterone Supplementation Options

For women with confirmed luteal phase deficiency, micronized progesterone (brand name Prometrium, 200 mg vaginally at bedtime from ovulation through cycle day 26 or until a negative pregnancy test) is a standard approach. Vaginal delivery produces higher uterine tissue concentrations than oral dosing for the same systemic level, a pharmacokinetic advantage known as the "first-uterine-pass effect" [11].

The PROMISE trial (2015, N=836) tested vaginal micronized progesterone 400 mg twice daily from the day of a positive pregnancy test through 11 weeks 6 days in women with unexplained recurrent miscarriage. It found no statistically significant difference in live birth rates (65.8% vs. 63.3%, P=0.45) [12]. However, a 2019 subgroup analysis of the PRISM trial (N=4,153) found that women with at least three prior miscarriages who received progesterone had a live birth rate of 72% versus 57% in the placebo group [13]. These two datasets together suggest progesterone supplementation may be most effective when recurrent loss is already established.

Estrogen Balance: More Than Just "Too Much or Too Little"

Estrogen is not a single hormone. The three primary forms are estradiol (E2), estrone (E1), and estriol (E3). Before pregnancy, estradiol drives follicular development and thickens the uterine lining. Estrogen dominance, a relative excess of estradiol compared with progesterone, is a common but loosely defined clinical pattern.

Signs of Estrogen Excess Before Pregnancy

Clinical signs include heavy or prolonged periods, breast tenderness, bloating, and worsening PMS. These often co-exist with low progesterone rather than an absolute estradiol excess. A cycle day 3 estradiol above 80 pg/mL can also indicate diminished ovarian reserve and may require further workup with FSH and AMH.

Estrogen Metabolism and DIM

Estrogen is metabolized in the liver along two primary pathways: the 2-hydroxy pathway (producing less active metabolites) and the 16-hydroxy pathway (producing more estrogenic metabolites). Diindolylmethane (DIM), a compound derived from cruciferous vegetables, shifts this ratio toward the 2-hydroxy pathway. A 2008 study in Nutrition and Cancer (N=60) found that DIM supplementation at 108 mg/day significantly increased 2-hydroxy estrogen metabolites in premenopausal women [14]. DIM is generally considered safe as a preconception supplement but should be disclosed to the treating clinician, as data in early pregnancy are limited.

Endometriosis and Estrogen

Women with endometriosis have a localized excess of estrogen within ectopic lesions due to upregulated aromatase activity. Managing endometriosis-related estrogen excess before conception typically involves surgical treatment (laparoscopic excision) rather than hormonal suppression, because GnRH agonists and progestins used to suppress endometriosis also suppress ovulation. The reproductive endocrinologist's timing of surgery relative to the conception attempt is therefore a key clinical decision.

Androgens: Testosterone and DHEA-S in the Preconception Period

Elevated androgens cause irregular cycles, anovulation, and reduced egg quality. They are most commonly elevated in PCOS but can also reflect congenital adrenal hyperplasia (CAH) or, rarely, an adrenal or ovarian tumor.

Testing Androgens

A standard panel includes total testosterone, free testosterone (or calculated free testosterone from SHBG), and DHEA-S. Draw these labs in the morning, preferably on cycle day 3 to 5, when values are most reproducible. In PCOS, free testosterone above 2 ng/dL or a free androgen index above 5 is commonly seen.

Lowering Androgens Before Conception

The clinical approach to elevated androgens before conception depends on their source:

• Ovarian androgens (PCOS): Lifestyle modification plus inositol is the first step. Metformin reduces ovarian androgen production by lowering LH and insulin. Spearmint tea (two cups daily) showed a modest but statistically significant reduction in free testosterone (from 1.02 to 0.77 ng/dL, P<0.05) over 30 days in a 2010 pilot RCT (N=41) [15].
• Adrenal androgens (elevated DHEA-S): Low-dose prednisone 2.5 to 5 mg at bedtime or low-dose dexamethasone 0.25 to 0.5 mg can suppress adrenal androgen overproduction. These are used cautiously and typically only when DHEA-S exceeds 350 mcg/dL with confirmed adrenal source.
• CAH: Requires specialist management with glucocorticoid replacement and genetic counseling before conception.

Spironolactone, commonly used for PCOS-related androgen excess, is contraindicated in pregnancy due to feminization risk to a male fetus. It must be discontinued at least one cycle before attempting conception.

Prolactin: The Often-Overlooked Fertility Blocker

Elevated prolactin (hyperprolactinemia) suppresses GnRH pulsatility, which in turn blunts LH and FSH release and can completely block ovulation. Any woman with irregular cycles and galactorrhea should have prolactin checked before a workup proceeds further.

Normal Values and When to Retest

A single fasting morning prolactin above 25 ng/mL warrants a repeat draw. Stress, a recent breast exam, or a large meal can all transiently raise prolactin. If two draws are elevated, an MRI of the pituitary should be considered to rule out a prolactinoma.

Cabergoline as First-Line Treatment

Cabergoline (Dostinex) 0.25 to 0.5 mg twice weekly is the preferred dopamine agonist for hyperprolactinemia in women planning pregnancy. A 2014 review in Clinical Endocrinology found normalization of prolactin in up to 90% of patients with microprolactinomas treated with cabergoline [16]. Once prolactin normalizes and conception is confirmed, cabergoline is typically discontinued, and most microprolactinomas do not enlarge significantly during pregnancy.

Key Nutrients That Support Preconception Hormone Balance

Hormones are synthesized from dietary precursors. Nutritional gaps, particularly in vitamin D, magnesium, zinc, iodine, and omega-3 fatty acids, can limit hormone production and clearance independent of any endocrine pathology.

Vitamin D

Vitamin D acts as a steroid hormone precursor and has receptors on ovarian follicles, endometrial cells, and pituitary gonadotrophs. A 2019 meta-analysis in Reproductive Biology and Endocrinology (N=2,700 across 11 RCTs) found that vitamin D sufficiency (serum 25-OH-D above 30 ng/mL) was associated with significantly higher clinical pregnancy rates in women undergoing IVF (OR 1.34, 95% CI 1.04 to 1.73) [17]. Check 25-OH-D before supplementing. If below 20 ng/mL, a loading strategy of 4,000 to 5,000 IU/day for 8 to 12 weeks followed by a maintenance dose is appropriate.

Magnesium

Magnesium participates in over 300 enzymatic reactions, including those governing insulin signaling and thyroid hormone synthesis. A deficiency (serum magnesium below 0.85 mmol/L) is present in approximately 25% of the general population [18]. Supplementing with magnesium glycinate 200 to 400 mg at bedtime may improve insulin sensitivity and reduce PMS-related progesterone symptoms over six to eight weeks.

Omega-3 Fatty Acids

DHA and EPA reduce systemic inflammation, which can suppress hypothalamic-pituitary function. The American College of Obstetricians and Gynecologists recommends 200 to 300 mg of DHA daily during preconception and pregnancy [19]. Most prenatal vitamins contain 200 mg or less. Women with inflammatory conditions may need 1,000 to 2,000 mg of combined EPA plus DHA.

Folic Acid and Methylfolate

The CDC recommends 400 mcg of folic acid daily starting at least one month before conception [20]. Women with the MTHFR C677T polymorphism (homozygous) convert folic acid to the active form (5-MTHF) less efficiently. For these women, a prenatal vitamin containing methylfolate (L-5-MTHF) rather than synthetic folic acid may be preferred, though direct head-to-head RCT data comparing clinical pregnancy outcomes by MTHFR status are limited.

Building a Preconception Lab Panel

A practical preconception lab panel, drawn ideally on cycle days 2 to 5 for hormonal markers, includes:

| Test | Clinical target (preconception) | |---|---| | TSH | 0.5 to 2.5 mIU/L | | Free T4 | Mid-to-upper half of reference range | | TPO antibodies | Negative preferred | | Fasting insulin | Below 10 µIU/mL | | HOMA-IR | Below 2.0 | | HbA1c | Below 5.7% | | Estradiol (cycle day 3) | 25 to 75 pg/mL | | FSH (cycle day 3) | Below 10 IU/L | | AMH | 1.0 to 3.5 ng/mL (age-dependent) | | Progesterone (cycle day 21) | Above 10 ng/mL | | Total testosterone | Below 50 ng/dL in women | | DHEA-S | 85 to 350 mcg/dL | | Prolactin | Below 25 ng/mL | | 25-OH vitamin D | 40 to 60 ng/mL |

Most of these are available through a standard reference laboratory. Some, including HOMA-IR and the free androgen index, must be calculated from the ordered values rather than ordered directly.

A Practical Three-to-Six-Month Preconception Timeline

The sequence of interventions matters as much as the interventions themselves.

Month 1: Draw the full lab panel above. Start prenatal vitamins with methylfolate (600 to 800 mcg) and DHA (200 to 300 mg). Begin low-glycemic-index dietary changes and introduce resistance training two to three days per week.

Month 2: Review labs with your clinician. Initiate levothyroxine if TSH is above 2.5 mIU/L or if TPO antibodies are positive. Start myo-inositol 4 g/day if HOMA-IR is above 2.5 or PCOS is confirmed. Address prolactin with cabergoline if elevated.

Month 3: Recheck TSH (dose titration may be needed), fasting insulin, and HOMA-IR. Confirm ovulation with cycle day 21 progesterone. If progesterone remains below 10 ng/mL, discuss luteal phase progesterone support.

Months 4 to 6: Fine-tune doses based on trending labs. Confirm vitamin D has reached 40 to 60 ng/mL. Discuss with your clinician whether to discontinue spironolactone (requires at least one full cycle off before conception attempts begin).